Catalog # 107117
1/3
Net Contents: 3 x 0.5 mL
Arachidonic Acid is for use in routine platelet aggregation studies for the differential diagnosis of aspirin-like release defects and Storage Pool Disease.
-
Assess the Effect of Aspirin on Platelet Aggregation
-
Detect the Presence of Aspirin-like Release Defects
-
Evaluate the Inhibition of TX A2 Production
-
Confirm Patient Compliance when Aspirin Monotherapy or Dual Antiplatelet Therapy (DAPT) are Prescribed
-
Shelf Life of Two Years
Catalog No. 101297
ARACHIDONIC ACID
Sodium Arachidonate
PRODUCT DETAILS
Arachidonic Acid is a fatty acid present in the granules and membranes of human platelets.
It is liberated from phospholipids and, in the presence of the enzyme cyclo-oxygenase, incorporates oxygen to form the endoperoxide prostaglandin G2 (PGG2). PGG2 is then quickly transformed to prostaglandin H2 (PGH2) which in turn is converted to thromboxane A2 a potent inducer of platelet aggregation. Ingestion of aspirin or aspirin-containing compounds inhibits cyclo-oxygenase mediated oxygen consumption, thus precluding all subsequent events leading to platelet aggregation.
